Edwards Lifesciences Corporation (BMV:EW)

Mexico flag Mexico · Delayed Price · Currency is MXN
1,806.80
+281.57 (18.46%)
At close: Aug 26, 2025
18.46%
Market Cap890.55B
Revenue (ttm)107.21B
Net Income (ttm)78.22B
Shares Outn/a
EPS (ttm)132.33
PE Ratio11.39
Forward PE31.78
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open1,793.41
Previous Close1,525.23
Day's Range1,778.45 - 1,808.37
52-Week Range1,280.34 - 1,808.19
Beta1.08
RSI76.49
Earnings DateOct 24, 2025

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solution... [Read more]

Sector Healthcare
Founded 1958
Employees 15,800
Stock Exchange Mexican Stock Exchange
Ticker Symbol EW
Full Company Profile

Financial Performance

In 2024, Edwards Lifesciences's revenue was $5.44 billion, an increase of 8.57% compared to the previous year's $5.01 billion. Earnings were $4.17 billion, an increase of 197.68%.

Financial numbers in USD Financial Statements

News

There is no news available yet.